4.5 Article

Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme

Journal

JOURNAL OF ANTIBIOTICS
Volume 61, Issue 8, Pages 503-508

Publisher

JAPAN ANTIBIOTICS RESEARCH ASSOC
DOI: 10.1038/ja.2008.67

Keywords

semisynthetic pyripyropene derivative; acyl-CoA : cholesterol acyltransferase (ACAT); ACAT isozyme; atherosclerosis

Funding

  1. National Institute of Biomedical Innovation (NIBIO)
  2. Ministry of Education, Culture, Sports, Science and Technology, Japan [18390008]
  3. Hoh-ansya Foundation, Japan
  4. Grants-in-Aid for Scientific Research [18390008] Funding Source: KAKEN

Ask authors/readers for more resources

Selectivity of 96 semisynthetic derivatives prepared from fungal pyripyropene A, originally isolated as a potent inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT), toward ACAT1 and ACAT2 isozymes was investigated in the cell-based assay using ACAT1- and ACAT2-expressing CHO cells. Eighteen derivatives including PR-71 (7-O-isocaproyl derivative) showed much more potent ACAT2 inhibition (IC(50): 6.0 to 62 nM) than pyripyropene A (IC(50): 70 nM). Among them, however, natural pyripyropene A showed the highest selectivity toward ACAT2 with a selectivity index (SI) of >1000, followed by PR-71 (SI, 667).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available